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Mammalian ageing is associated with reduced regenerative capacity in tissues that contain stem cells 1, 2 . It has been proposed that this is at least partially caused by the senescence of progenitors with age 3, 4 ; however, it has not yet been tested whether genes associated with senescence functionally contribute to physiological declines in progenitor activity. Here we show that progenitor proliferation in the subventricular zone and neurogenesis in the olfactory bulb, as well as multipotent progenitor frequency and self-renewal potential, all decline with age in the mouse forebrain. These declines in progenitor frequency and function correlate with increased expression of p16
INK4a
, which encodes a cyclin-dependent kinase inhibitor linked to senescence 5 . Ageing p16
-deficient mice showed a significantly smaller decline in subventricular zone proliferation, olfactory bulb neurogenesis, and the frequency and self-renewal potential of multipotent progenitors. p16
INK4a deficiency did not detectably affect progenitor function in the dentate gyrus or enteric nervous system, indicating regional differences in the response of neural progenitors to increased p16
INK4a expression during ageing. Declining subventricular zone progenitor function and olfactory bulb neurogenesis during ageing are thus caused partly by increasing p16
INK4a expression. Stem cells must persist throughout adult life in numerous tissues, including the central nervous system (CNS) 6 , in order to replace the mature cells that are lost to turnover, injury, or disease. However, the function of stem cells and other progenitors declines with age in diverse tissues including the haematopoietic system [7] [8] [9] , muscle 10, 11 and brain 6, 12, 13 . Consistent with this, ageing tissues exhibit reduced repair capacity and an increased incidence of degenerative disease 1, 4 . However, the mechanisms responsible for the age-related decline in the function of stem cells and other progenitors remain uncertain. p16 INK4a gene expression increases with age in a variety of tissues [14] [15] [16] . Although induction of p16 INK4a expression can cause the senescence of a variety of cell types in culture 5, 17 and in vivo 18 , some cells (including some neural progenitors) are unaffected by increased p16
INK4a expression or p16 INK4a deletion [19] [20] [21] . It is thus unclear whether increased p16
INK4a expression causes declines in progenitor function during ageing in vivo. We have addressed this question by examining progenitor frequency, proliferation and neurogenesis in the forebrain lateral ventricle subventricular zone (SVZ) of ageing wild-type and p16
INK4a -deficient mice. The SVZ contains a mixed population of stem cells and other progenitors that engage in neurogenesis throughout adult life 6, 13, 22 . The rate of neurogenesis is known to decline in ageing mammals 13 , but the physiological mechanisms responsible for this decline have not been identified.
We compared various measures of progenitor function in the SVZ of 60-day-old, 1-yr-old and 2-yr-old mice to determine the effects of ageing. Consistent with a previous study 6 , we found a twofold reduction with age in the frequency of SVZ cells that formed multipotent neurospheres in culture ( Fig. 1a ; asterisk, P , 0.05). This was associated with an approximately twofold reduction in the selfrenewal potential of these multipotent neurospheres ( Fig. 1b ; asterisk, P , 0.05). In vivo, we observed an approximately threefold reduction in the rate of proliferation in the SVZ with age ( Fig. 1c, d ; asterisk, P , 0.05). These data suggest that stem cell frequency and selfrenewal potential, as well as overall proliferation rate, decline with age in the SVZ.
Adult Bmi1-deficient mice also exhibit reduced stem cell frequency and self-renewal potential, as well as reduced proliferation in the SVZ 20 . These effects are largely caused by increased p16 INK4a and Arf expression in the absence of Bmi1 (refs 19-21) . We therefore wondered whether the age-related changes observed in wild-type mice ( Fig. 1) were associated with increased p16
INK4a or Arf expression in neural progenitors. p16
INK4a and Arf expression increase with age in some tissues 15, 16 , although these studies did not examine neural progenitors. We did not detect any age-related increase in Arf expression in uncultured SVZ cells at the RNA or protein levels (data not shown). In contrast, p16
INK4a expression increased substantially with age in uncultured SVZ cells (Fig. 1e) . p16
INK4a expression was not detectable by polymerase chain reaction (PCR) in the SVZ of 60-day-old mice, but became detectable by 1 yr of age and further increased by 2 yr of age. We were not able to detect p16
INK4a protein in the SVZ by western blot, consistent with previous studies that have also not been able to detect this protein in most uncultured mouse tissues that express p16
INK4a mRNA 15, 16 , presumably due to its low expression level and the limited sensitivity of available antibodies.
To test the function of p16 INK4a in ageing neural progenitors we examined young (60-day-old) and old (2-yr-old) p16
INK4a -deficient mice as well as littermate controls. p16
INK4a deficiency did not grossly affect the composition of the SVZ, with similar proportions of SVZ cells staining positively for the glia marker GFAP or the neuroblast marker doublecortin in wild-type and p16
INK4a -deficient mice irrespective of age (data not shown). Similarly, apoptotic SVZ cells (activated caspase-3 þ ) were rare in all treatments (data not shown).
Deletion of p16
INK4a in young mice did not significantly affect the frequency of SVZ cells that formed multipotent neurospheres in culture (Fig. 2a) , or the self-renewal potential of these cells upon subcloning (Fig. 2b) . This is consistent with our failure to detect p16
INK4a expression in SVZ cells from young mice in vivo, as well as with previous studies 19, 20 . In contrast, p16 INK4a deficiency in old mice significantly increased the frequency of SVZ cells that formed multipotent neurospheres in culture ( Fig. 2a; hash, P , 0.05 relative to old wild-type mice), as well as the self-renewal potential of these cells ( Fig. 2b ; hash, P , 0.05 relative to old wild-type mice). Consistent with this finding, the rate of proliferation among SVZ cells in vivo was also significantly increased by p16
INK4a deficiency in old but not young mice ( Fig. 2c ; hash, P , 0.05 relative to old wildtype mice). Nonetheless, the percentage of proliferating cells in old p16
INK4a
-deficient mice was still significantly less than observed in normal or p16
-deficient young mice ( Fig. 2c ; asterisk, P , 0.05 relative to young mice). Like old wild-type mice, old p16
-deficient mice also exhibited enlarged lateral ventricles due to cortical atrophy (Fig. 1c , data not shown). These observations indicate that p16
INK4a deficiency partially rescued the age-related declines in progenitor activity in the SVZ but did not prevent cortical atrophy. p16 INK4a deficiency seemed to rescue completely the age-related decline in cells that can form stem cell colonies in culture (Fig. 2a) , while only partially rescuing the overall decline in SVZ proliferation (Fig. 2c) . One possibility that would be consistent with previous studies of p16 INK4a in neural progenitors [19] [20] [21] is that p16
expression had a greater effect on SVZ stem cells than on downstream progenitors. A number of studies have argued that stem cells can be identified within the SVZ based on their ability to retain the DNA replication label 5-bromodeoxyuridine (BrdU; stem cells divide infrequently and are retained within the SVZ while other progenitors divide continuously before migrating out of the SVZ) [22] [23] [24] [25] . Therefore, we examined the effects of age and p16
INK4a deficiency on the frequency of BrdU label-retaining cells. We administered BrdU for 8 days, followed by a 4-week chase with no BrdU, then killed the mice. p16
INK4a deficiency had no effect on the frequency of label-retaining cells in the young adult SVZ (Fig. 2d) . The frequency of labelretaining cells declined significantly in old wild-type mice but not in old p16
-deficient mice (Fig. 2d) . Thus, the frequencies of label-retaining cells in vivo exhibited similar trends as observed for the frequencies of cells that could form multi-lineage colonies in culture. These data suggest that p16
INK4a deficiency can largely rescue the age-related decline in the frequency of early progenitors within the SVZ.
SVZ progenitors form neuroblasts throughout life that migrate into the olfactory bulb and differentiate into neurons 13, 22 . To test whether the increase in p16
INK4a expression within the SVZ also affects neurogenesis, we examined the effects of age and p16
deficiency on the generation of new neurons in the olfactory bulb. We administered BrdU to mice for 8 days to mark dividing progenitors, followed by a 4-week chase period with no BrdU (during which neurons could migrate and differentiate), then killed the mice to analyse sections through the olfactory bulb by confocal microscopy. As we observed for progenitor function, p16
INK4a deficiency had no effect on neurogenesis in young mice, but neurogenesis significantly decreased with age, and p16
INK4a deficiency significantly increased the frequency of newly generated olfactory bulb neurons in 15-19-month-old mice (Fig. 3i) . Notably, p16
INK4a deficiency had no effect on the frequency of non-neuronal cells within the olfactory INK4a causes age-related declines in stem and progenitor cell function in the SVZ. a, The percentage of SVZ cells that formed multipotent neurospheres in culture significantly declined in 2-yr-old wild-type mice as compared with 60-day-old mice (asterisk, P , 0.01) but significantly increased in old mice with p16
INK4a deficiency (hash, P , 0.01 relative to old wild-type mice). b, Self-renewal potential (the number of secondary neurospheres generated per subcloned primary neurosphere) significantly declined in old wild-type mice as compared to young mice (asterisk, P , 0.05). p16
INK4a deficiency significantly increased the self-renewal of neurospheres from old but not young mice (hash, P , 0.05 relative to old wild-type mice). c, The percentage of SVZ cells that incorporated a 2-h pulse of BrdU significantly declined in old as compared to young mice (asterisk, P , 0.01), but significantly increased in old mice with p16
INK4a deficiency (hash, P , 0.01 relative to old wild-type mice). d, The frequency of BrdU label-retaining cells in the SVZ significantly declined in old wild-type mice as compared with young wild-type mice (asterisk, P , 0.05), but significantly increased in old mice with p16
INK4a deficiency (hash, P , 0.05 relative to old wild-type mice). All values are mean^s.d. for at least three independent experiments. All mice were histologically negative for intracranial neoplasms. Figure 1 | Neural progenitor function declines with age. a, The percentage of SVZ cells that formed multipotent neurospheres in culture declined with age (asterisk, P , 0.05 relative to 60-day-old mice; three independent experiments; 5-6 mice per age; error bars for all panels are^s.d.). b, The self-renewal potential of these primary neurospheres also declined with age (asterisk, P , 0.05; three independent experiments; 5-6 mice per age). c, d, Proliferation in the SVZ (percentage of BrdU þ cells after a 2-h pulse) also declined significantly with age (three mice per age; 5-7 sections per mouse). The SVZ thinned in old mice (c, arrows), and the lateral ventricle expanded (asterisk) due to cortical atrophy (c, lateral ventricle is not visible at this magnification in young mice; scale bar, 200 mm). e, p16
INK4a mRNA expression increased with age as detected by quantitative (real-time) PCR in uncultured SVZ cells (three independent samples per age). Note that 1-yr-old samples were set to 1.0 as the reference sample. ND, not detected. bulb (Fig. 3j) . This may at least partially reflect our previous observation that changes in p16
INK4a expression do not appear to affect gliarestricted progenitors 20 . p16
INK4a deficiency thus partially rescued the age-related decline in neurogenesis in the olfactory bulb in addition to rescuing partially the decline in progenitor function in the SVZ.
To test whether these effects of p16 INK4a occurred throughout the CNS, we also examined the effect of p16
INK4a deficiency on progenitor activity and neurogenesis in the dentate gyrus 26 . The rates of progenitor proliferation and neurogenesis in the dentate gyrus decline markedly with age 12 . To test whether this is affected by p16
INK4a , we administered BrdU for 8 days to mark proliferation in the subgranular layer, followed by a 4-week chase period without BrdU to examine neurogenesis in the granular layer. p16 INK4a deficiency did not significantly affect the rate of proliferation among progenitors in the subgranular layer, or the frequency of BrdU þ NeuN þ newly generated neurons or BrdU þ NeuN 2 nonneuronal cells in the granular layer of the dentate gyrus (Supplementary Fig. 1) . Thus, although p16
INK4a deficiency consistently increased all measures of progenitor activity and neurogenesis in the ageing subventricular zone/olfactory bulb, it did not detectably affect proliferation or neurogenesis in the dentate gyrus.
We also examined the effect of age and p16 INK4a deficiency on the neural crest stem cells that persist throughout adult life in the enteric nervous system (in the gut wall) 19, 20, 27 . The frequency of these neural crest stem cells declined with age, and p16
expression increased with age in p75 þ (neurotrophin-receptor expressing) gut cells enriched for neural crest stem cells (Supplementary Fig. 2 ). However, p16
INK4a deficiency had no effect on neural crest stem cell frequency in young or old mice. These results indicate that although the age-related increase in p16
INK4a expression causes a decline in SVZ progenitor function and neurogenesis, other mechanisms are more important in the ageing of stem and progenitor cells in the hippocampus and peripheral nervous system.
The mechanisms that account for the increase in p16
expression with age remain unclear. In principle, p16 INK4a expression could be developmentally programmed to increase with age to counter the increasing incidence of cancer that is observed in the ageing nervous system. Alternatively, p16
INK4a expression may reflect the induction of senescence in ageing cells in response to damage that accumulates from oxidative metabolism or other stresses. Although Bmi1 is important for p16
INK4a repression 19,20,28 , we did not detect any change in Bmi1 expression with age at the RNA or protein levels in SVZ cells (Supplementary Fig. 3 ). Nonetheless, subtle reductions in Bmi1 expression or activity cannot be excluded and could be functionally important, as even the twofold reduction in Bmi1 expression in Bmi1 2/þ mice leads to increased p16 INK4a expression (data not shown). Additional work will be required to resolve the potentially multifactorial mechanisms that regulate age-related changes in p16
INK4a expression. The simplest interpretation of our data is that p16
INK4a acts cell autonomously within neural stem cells, because p16
INK4a deficiency increased the self-renewal of single neural stem cells in culture. However, we cannot exclude the possibility of non-cell-autonomous effects by p16
INK4a in vivo. In addition to investigating this issue further, it will also be of interest to determine whether circulating humoral factors 11 influence p16 INK4a expression during ageing. One study found that moderately increased expression of p16
and p19 ARF in transgenic mice does not detectably accelerate gross measures of ageing or change lifespan, despite reducing cancer incidence 29 . However, that study did not examine neural progenitor function or neurogenesis. We also examined p16
INK4a bacterial artificial chromosome (BAC) transgenic mice that exhibited a moderate increase in p16
INK4a expression and found no effect of p16
INK4a overexpression on stem cell frequency or self-renewal potential, although old transgenic mice did exhibit a modest reduction in SVZ proliferation (data not shown). It seems that the levels of p16
INK4a that are required to deplete stem cells are qualitatively higher than the levels that are required to inhibit carcinogenesis. Together, the data suggest that although physiological increases in p16
INK4a expression during ageing reduce neural progenitor function and neurogenesis in the SVZ/olfactory bulb, modest overexpression of p16
INK4a does not substantially amplify these effects or accelerate gross measures of ageing.
Although physiological p16 INK4a expression reduces stem/progenitor cell function and neurogenesis with age, how this relates to overall ageing or lifespan remains unclear. It is difficult to examine the effect of p16
INK4a deficiency on mouse lifespan because p16
deficiency increases cancer incidence 30 in addition to affecting agerelated changes in stem/progenitor cell function. Declining stem/ progenitor cell function may be a major cause of the decline in regenerative capacity and the increase in degenerative disease that is observed in ageing tissues. On the other hand, increases in the death or dysfunction of mature cells in ageing tissues also contribute to agerelated morbidity. It is similarly unknown whether physiological differences in the rate at which stem/progenitor cell activity declines with age has a detectable impact on longevity. The fact that p16
did not affect progenitors in certain regions of the nervous system suggests that p16
INK4a is not likely to promote generically the ageing of all cells. Indeed, it is likely that there will be important differences between tissues, and perhaps between progenitor cells and differentiated cells, in terms of the genes that regulate the ageing process. Although these questions remain unanswered, it may be possible to gain important new insights into the ageing process at a cellular level by studying individual cell types that have known physiological functions in vivo, such as haematopoietic or neural stem cells.
Our data suggest that stem cell function is regulated by a balance between proto-oncogenes, like Bmi1 (that promote stem cell maintenance and regenerative capacity but can also contribute to neoplastic proliferation), and tumour suppressors, like p16
INK4a (that reduce regenerative capacity and promote ageing but also reduce cancer incidence). This balance changes with age and is influenced by other proto-oncogenes and tumour suppressors that also regulate p16
INK4a expression. The networks of proto-oncogenes and tumour suppressors that regulate stem cell self-renewal, cancer cell proliferation and stem cell ageing may have evolved to balance the need for regenerative capacity while guarding against the increasing risk of neoplasms with age. p16
INK4a thus reduces cancer incidence 5, 30 but also contributes to ageing by reducing progenitor function and neurogenesis in at least certain regions of the nervous system.
METHODS

Mice. p16
INK4aþ/2 mice were backcrossed at least six times onto a C57BL background. p16
INK4a genotyping was performed by PCR as described 30 . Isolation of CNS progenitors. Adult SVZ was obtained by microdissecting the lateral walls of the lateral ventricles, then dissociating for 20 min at 37 8C in 0.025% trypsin/0.5 mM EDTA (Calbiochem) plus 0.001% DNase1 (Roche). After quenching the enzymatic dissociation with staining medium (L15 medium containing 1 mg ml 21 BSA (Sigma A-3912), 10 mM HEPES (pH 7.4) and 1% penicillin/streptomycin (BioWhittaker)) containing 0.014% soybean trypsin inhibitor (Sigma) and 0.001% DNase1, the cells were washed and re-suspended in staining medium, triturated, filtered through nylon screen (45 mm, Sefar America), counted by haemocytometer, and plated. Cell culture and self-renewal assay. Cells were plated at clonal density (1.3 cells per ml) on ultra-low-binding plates (Corning) to grow neurospheres. Culture medium was based on a 5:3 mixture of DMEM-low glucose as described previously 19 : neurobasal medium (Gibco) supplemented with 20 ng ml 21 human bFGF (R&D Systems), 20 ng ml 21 EGF (R&D Systems), 1% N2 supplement (Gibco), 2% B27 supplement (Gibco), 50 mM 2-mercaptoethanol, 1% penicillin/streptomycin (Biowhittaker), and 10% chick embryo extract. Cultures were maintained at 37 8C in 6% CO 2 /balance air. To measure self-renewal, individual neurospheres were dissociated by trituration then replated at clonal density as above. Secondary neurospheres were counted 5-10 days later to determine the number of secondary neurospheres formed per primary neurosphere. CNS neurospheres were tested for multipotency by replating one neurosphere per well into 48-well plates and then culturing adherently for 3-5 days before triple staining for oligodendrocytes (O4), neurons (TuJ1) and astrocytes (GFAP). See Supplementary Methods for details. BrdU incorporation/proliferation assays. To quantify SVZ proliferation, mice were injected intraperitoneally with 50 mg kg 21 of BrdU (Sigma), and killed 2 h after BrdU injection. To quantify proliferation in the dentate gyrus, mice received a single injection of 50 mg kg 21 BrdU, followed by 1 mg ml 21 BrdU in their drinking water for 8 days before being killed and analysed. To quantify neurogenesis in the dentate gyrus and the olfactory bulb and BrdU retention in the SVZ, mice were treated with BrdU for 8 days. However, the animals were then taken off of BrdU for 4 weeks before the animals were killed. The brains were dissected, fixed in 4% paraformaldehyde overnight, then cryo-protected in 15% sucrose, embedded in 7.5% gelatin/15% sucrose, and flash frozen. Twelvemicrometre sections were cut on a Leica cryostat.
For detection of BrdU in the tissue sections, DNA was denatured in 2 M HCl for 30 min at room temperature and neutralized with 0.1 M sodium borate. Sections were pre-blocked for 1 h at room temperature in goat serum solution (PBS containing 5% goat serum, 1% BSA and 0.3% Triton X-100 (Sigma)). Primary rat anti-BrdU (1:500, Accurate Chemical) diluted in goat serum solution was incubated overnight at 4 8C, followed by fluorescein isothiocyanate (FITC)-conjugated anti-rat Fc fragment (Jackson Labs) for 3-4 h at room temperature. Slides were counter stained in 2.5 mg ml 21 DAPI for 10 min at room temperature, then mounted using ProLong antifade solution (Molecular Probes). Numbers of BrdU-labelled cells were divided by total DAPI þ or NeuN þ nuclei.
To ensure that BrdU incorporation results were not skewed by dividing endothelial or haematopoietic cells, we double-labelled SVZ sections with antibodies against BrdU and either anti-CD45 (to identify blood cells) or anti-VE-cadherin (to identify endothelial cells). We did not detect any BrdU þ haematopoietic or endothelial cells.
Western blots and quantitative RT-PCR were performed as described in Supplementary Information. Statistical analysis. Experiments that involved multiple treatments were initially analysed by analysis of variance. Statistically significant results were followed up with Student's t-tests. Confocal analysis of neurogenesis in the olfactory bulb. A Zeiss LSM 510 confocal laser-scanning microscope was used to obtain 25-30 random fields of view throughout all regions of one entire olfactory bulb of each mouse with a £40 or £63 objective lens. For each image, 1-mm-thick optical sections were scanned with three different lasers through a 12-mm sagittal tissue section creating a Z-series stack with three distinct channels of fluorescence. An ultraviolet enterprise laser was used to detect the DAPI signal labelling all nuclei. An argon laser detected FITC (BrdU), and a HeNe laser detected Cy3 (NeuN). Channels were merged together to determine whether DAPI, BrdU and NeuN signals co-labelled at every 1-mm slice of the Z-series. Three-dimensional projections were made using LSM 510 software.
